MED50 Flu Vaccine 2016-2017season

The Commonwealth of Massachusetts is seeking bids for a Statewide Contract to acquire Influenza Vaccine for the 2016-2017 flu season. The contract opportunity, identified as MED50, is being jointly issued by the Executive Office for Administration and Finance (ANF), the Office of the Comptroller (CTR), and the Operational Services Division (OSD). The contract will be used primarily by the Massachusetts Department of Public Health's Immunization Program, but will also be available for use by other eligible entities such as cities, towns, and state colleges. The procurement is seeking bids for various forms of quadrivalent influenza vaccines, including injectable and nasal spray formulations, in different dosages for infants, children, and adults. Bidders must meet strict qualification requirements and provide detailed pricing, delivery schedules, and product specifications. The evaluation criteria will be 80% price, 10% Supplier Diversity Plan, and 10% prompt payment discounts and environmentally preferable products.

The Commonwealth has designated this contract opportunity for participation by Minority Business Enterprises (MBE), Women Business Enterprises (WBE), and Service-Disabled Veteran-owned Business Enterprises (SDVOBE). Bidders must commit to a specific percentage of contract sales to be spent with certified SDP partners and submit the required SDP Plan forms. The estimated contract value is $5 million based on historical purchasing, with no maximum obligation amount specified. The contract term is from March 1, 2016 to February 28, 2017, with the option to renew for up to two additional one-year terms.